Clinical Trials Logo

Postsurgical Pain clinical trials

View clinical trials related to Postsurgical Pain.

Filter by:

NCT ID: NCT04647435 Recruiting - Postsurgical Pain Clinical Trials

Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction

CARLOTA
Start date: May 13, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of APSCTC compared to two active drugs in acute pain relief.

NCT ID: NCT04203537 Completed - Postsurgical Pain Clinical Trials

Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)

Start date: December 4, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

In the pilot (Part A) of this study, multiple doses of CA-008 (vocacapsaicin) were evaluated for safety, tolerability, and PK. Doses were then selected for the expanded part (Part B) of the study, where CA-008 was compared to placebo. Patients had serial assessments of safety, PK, and drug effect.

NCT ID: NCT03789318 Completed - Postsurgical Pain Clinical Trials

Study in Subjects Undergoing Complete Abdominoplasty

Start date: December 3, 2018
Phase: Phase 2
Study type: Interventional

Phase 2, single center, randomized, double-blind, placebo-controlled, parallel design study of CA-008 vs. placebo in subjects undergoing an elective C-ABD under general anesthesia supplemented with a bupivacaine hydrochloride (HCl)transverse abdominis plane (TAP) block.

NCT ID: NCT03731364 Completed - Postsurgical Pain Clinical Trials

Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty

Start date: October 29, 2018
Phase: Phase 2
Study type: Interventional

This is a two-part, Phase 2, multi-center, randomized, double-blind, placebo-controlled, parallel design study of CA-008 (vocacapsaicin) vs. placebo injected/instilled during an elective TKA.

NCT ID: NCT02081703 Completed - Postsurgical Pain Clinical Trials

Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery

Start date: May 2014
Phase: Phase 2
Study type: Interventional

The objectives of this study are to evaluate the safety and analgesic efficacy of a single preoperative intrathecal administration of AYX1 Injection at two dose/volume levels.

NCT ID: NCT01731730 Completed - Postsurgical Pain Clinical Trials

Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery

Start date: January 2013
Phase: Phase 2
Study type: Interventional

The objectives of this proof of concept study are to evaluate the safety and preventive analgesic efficacy of a single preoperative intrathecal administration of AYX1 Injection in patients undergoing unilateral total knee arthroplasty.

NCT ID: NCT01582477 Completed - Analgesia Clinical Trials

TAP-patients With Robotic Assisted Lap Prostatectomy

TAP
Start date: March 2012
Phase: Phase 4
Study type: Interventional

The purpose of the study is to assess the safety and efficacy of EXPAREL when administered via infiltration into the transversus abdominis plane (TAP) to prolonged postsurgical analgesia in men undergoing robot-assisted laparoscopic prostatectomy.

NCT ID: NCT01562483 Completed - Chronic Pain Clinical Trials

The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain

Start date: October 2012
Phase: Phase 2
Study type: Interventional

Persistent postsurgical abdominal pain (PPAP) is a very difficult to treat pain. This pain can persist for months or even years and significantly diminishes quality of life. The exact underlying cause for this pain persistence is still unclear, which makes its treatment still a challenge. The promising analgesic effects of Δ9-THC in previous research, plus the improved bioavailability of Namisol® in comparison with previous Δ9-THC substances form the basis of the present research proposal. The current study aims to investigate the analgesic efficacy of Namisol® as add-on analgesic during a long-term treatment (52 days) of persistent postsurgical abdominal pain.